Universal Beteiligungs und Servicegesellschaft mbH Buys 34,881 Shares of Inspire Medical Systems, Inc. $INSP

Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 990.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 38,404 shares of the company’s stock after acquiring an additional 34,881 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Inspire Medical Systems were worth $3,542,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in INSP. Xponance Inc. boosted its holdings in shares of Inspire Medical Systems by 2.9% during the 3rd quarter. Xponance Inc. now owns 4,177 shares of the company’s stock valued at $310,000 after acquiring an additional 116 shares in the last quarter. Daiwa Securities Group Inc. boosted its holdings in shares of Inspire Medical Systems by 38.7% during the 2nd quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock valued at $60,000 after acquiring an additional 130 shares in the last quarter. Blair William & Co. IL boosted its holdings in shares of Inspire Medical Systems by 5.1% during the 3rd quarter. Blair William & Co. IL now owns 4,865 shares of the company’s stock valued at $361,000 after acquiring an additional 234 shares in the last quarter. CWM LLC boosted its holdings in shares of Inspire Medical Systems by 216.1% during the 4th quarter. CWM LLC now owns 354 shares of the company’s stock valued at $33,000 after acquiring an additional 242 shares in the last quarter. Finally, XTX Topco Ltd boosted its holdings in shares of Inspire Medical Systems by 4.3% during the 3rd quarter. XTX Topco Ltd now owns 7,289 shares of the company’s stock valued at $541,000 after acquiring an additional 300 shares in the last quarter. Institutional investors own 94.91% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on INSP shares. Oppenheimer downgraded Inspire Medical Systems from an “outperform” rating to a “market perform” rating in a report on Thursday, January 22nd. UBS Group set a $67.00 price objective on Inspire Medical Systems in a report on Friday, February 13th. Piper Sandler cut their price objective on Inspire Medical Systems from $165.00 to $85.00 and set an “overweight” rating on the stock in a report on Thursday, February 12th. Jefferies Financial Group cut their target price on Inspire Medical Systems from $81.00 to $66.00 and set a “hold” rating on the stock in a report on Thursday, February 12th. Finally, Stifel Nicolaus cut their target price on Inspire Medical Systems from $85.00 to $70.00 and set a “buy” rating on the stock in a report on Friday, April 10th. Five research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $101.41.

Inspire Medical Systems Trading Down 3.3%

Shares of INSP opened at $53.30 on Thursday. The company has a market capitalization of $1.53 billion, a PE ratio of 10.70, a PEG ratio of 2.84 and a beta of 0.86. Inspire Medical Systems, Inc. has a 12 month low of $48.30 and a 12 month high of $163.35. The stock’s 50-day moving average price is $56.81 and its two-hundred day moving average price is $79.79.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Wednesday, February 11th. The company reported $1.65 EPS for the quarter, topping the consensus estimate of $0.69 by $0.96. The firm had revenue of $269.08 million for the quarter, compared to the consensus estimate of $264.02 million. Inspire Medical Systems had a return on equity of 10.96% and a net margin of 15.95%.The business’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.15 EPS. Equities research analysts predict that Inspire Medical Systems, Inc. will post 1.82 EPS for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.